Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

SMC: Celgene’s Abraxane ‘too expensive’ for Scotland

But medicines watchdog backs Sovaldi, Invokana, Defitelio, Relvar Ellipta

- PMLiVE

Horizon adds AZ’s Galbraith to board

UK genomics company also appoints Susan Searle

- PMLiVE

MSA Market Media expands

Ben Mansfield joins as client services director and digital consultant

- PMLiVE

Grünenthal launches pain initiatives in Europe

Launches website for patients in Spain and grants German contract to B & F Brüggemann

EU flag

EFPIA: pharma must play key role in healthcare reform

Trade body publishes strategy to put industry at heart of economic growth

- PMLiVE

Myeloma UK and M3 launch education programme

Will use Doctors.net.uk online network

- PMLiVE

FDA approves Biogen Idec’s haemophilia drug

Eloctate now available to help control and prevent bleeding episodes

- PMLiVE

EMA adaptive licensing project gathers pace

Regulator picks two drugs to pilot early access scheme

- PMLiVE

Former Merck & Co exec to lead Seres

Roger Pomerantz was senior VP at pharma giant

Pharma deals during May 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for May 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Pradaxa cleared for new indications in Europe

Boehringer drug set for use in deep vein thrombosis and pulmonary embolism

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links